RDInvesting Provides Investors with Free In-Depth Equity Reports on CSLT, GEVA, JKS and RLGY

Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous s stock reports and market updates.

Castlight Health Inc. (NYSE:CSLT - News) shares declined 7.18 percent to close at $18.09 a share Tuesday. The stock traded between $18.01 and $20.25 on volume of 1.77 million shares traded. Analysts at Raymond James have recently initiated coverage on the company with an "outperform" rating and a price target of $26.00. Shares of Castlight Health have fallen approximately 55.0 percent year-to-date.

Find out more about Castlight Health including full access to the free equity report at:
www.RDInvesting.com/CSLT

Synageva BioPharma Corp. (NASDAQ:GEVA - News) shares increased 2.77 percent to close at $78.76 a share Tuesday. The stock traded between $73.42 and $82.67 on volume of 355,326 shares traded. Analysts at Wedbush have recently upgraded the company’s rating to "outperform" from "neutral". Shares of Synageva BioPharma have gained approximately 21.0 percent year-to-date.

Find out more about Synageva BioPharma including full access to the free equity report at:
www.RDInvesting.com/GEVA

JinkoSolar Holding Co., Ltd. (NYSE:JKS - News) shares increased 6.23 percent to close at $29.00 a share Tuesday. The stock traded between $28.27 and $29.40 on volume of 2.30 million shares traded. Analysts at Barclays have recently initiated coverage on the company with an “overweight” rating and a price target of $51.00. Shares of JinkoSolar Holding have fallen approximately 1.0 percent year-to-date.

Find out more about JinkoSolar Holding including full access to the free equity report at:
www.RDInvesting.com/JKS

Realogy Holdings Corp. (NYSE:RLGY - News) shares increased 1.37 percent to close at $42.99 a share Tuesday. The stock traded between $42.42 and $43.50 on volume of 1.89 million shares traded. Analysts at RBC Capital Markets have recently initiated coverage on the company with an "outperform" rating. Shares of Realogy Holdings have fallen approximately 13.0 percent year-to-date.

Find out more about Realogy Holdings including full access to the free equity report at:
www.RDInvesting.com/RLGY

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Research Driven Investing
info@rdinvesting.com